Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Capital Hilton

28 oct 2024 8:30 a.m. - 30 oct 2024 12:40 p.m.

1001 16th Street NW, Washington, DC 20036-5794

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Health & Safety

DIA remains committed to the health and well-being of our attendees and is closely monitoring news and guidance from the Centers for Disease Control & Prevention (CDC). World Health Organization (WHO), and the event’s local health agency to monitor our Health and Safety Protocols and ensure we are hosting the safest events possible.

DIA recognizes that COVID-19 is an evolving situation and will work closely with each venue and our suppliers to implement specific health and safety protocols appropriate to the public health circumstances existing at the time of the applicable event.

Based on the current guidance, DIA’s current Health and Safety Protocol is as follows:

  • DIA strongly encourages all participants to be fully vaccinated and complete a self-screening within 72-hours of arriving at the conference.
  • DIA will follow Washington, DC local health department guidelines.

We are continuously evolving health and safety protocols to ensure the safety of attendees; updates will be posted on this page.

Do not attend if at any time 5 days prior to the event you have received a positive COVID-19 test results, have knowingly been exposed to COVID-19, or have flu like symptoms.

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.